G-CSF implicated as therapeutic target in APLAID

Nature Reviews Rheumatology, Published online: 09 May 2023; doi:10.1038/s41584-023-00973-xCharacterization of a new mouse model highlights allogeneic bone marrow transplantation and granulocyte colony-stimulating factor neutralization as potential avenues for the treatment of APLAID.

Source: Nature Reviews Rheumatology - May 9, 2023 Category: Rheumatology Authors: Jessica McHugh Source Type: research